Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activin B is a dimeric protein belonging to the TGF-β superfamily, composed of two βB subunits. It regulates diverse biological processes, including embryogenesis, bone remodeling, hematopoiesis, and reproductive physiology. It signals through type II and type I activin receptors, activating Smad proteins and modulating gene transcription. Recent research indicates its role in promoting liver fibrosis via hepatic stellate cell activation, making it a potential therapeutic target for fibrotic diseases.
TGF-beta signaling via ActRIIA/ActRIIB and ActRIA/ALK4 or ActRIB/ALK7 receptors, leading to Smad2/Smad3 phosphorylation and downstream gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activin B (INHBB).